Dentsply Sirona Inc. announced that Simon Campion has been appointed President and Director, effective September 12, 2022. About Simon Campion: Simon Campion previously served as Executive Vice President & President of the Interventional and Medical segments at BD (Becton, Dickinson and Company) and prior to that served as President of the Interventional segment following BD's acquisition of C. R. Bard. When BD acquired C. R. Bard in 2017, he initially led the integration of the BD & Bard Surgery businesses into a single business unit and upon taking on the role of Executive Vice President & President of Interventional, a $4.2 billion segment in 2021, led the broader segment through integration, and oversaw the global strategic, financial and innovation performance of the segment.

Mr. Campion's leadership generated revenue growth at scale through expansion of the segment's organic innovation agenda and acceleration of its M&A objectives. Prior to BD's acquisition of C. R. Bard, Mr. Campion held several leadership roles across the C. R. Bard organization in the U.S. and Internationally, including President of the Surgery business unit. Previously he held marketing and R&D roles at Cook Medical and Boston Scientific.

Mr. Campion earned a Bachelor of Engineering and Ph.D. in Mechanical Engineering from the University of Limerick, Ireland and an MBA from the Open University in the UK.